The recent upsurge of interest in the complex problems of cerebrovascular disease is laudable for many reasons, the most important of which is the sobering fact that vascular lesions affecting the central nervous system account for 11.5% of all deaths and rank third in the list of causes of death, below diseases of the heart and malignant neoplasms. Meetings such as the Third Princeton Conference, The International Conference on Vascular Disease of the Brain, and the Symposium of the Houston Neurological Society are examples of the increasing emphasis being placed on the study of vascular diseases of the nervous system. These conferences have a salutary effect by bringing together groups of scientists who exchange information in this rapidly developing field. Several cooperative studies on the use of anticoagulant drugs in occlusive cerebrovascular disease have reached the stage of final reports. A cooperative study on subarachnoid hemorrhage and intracranial aneurysms now
SAHS AL. Extracerebral Neurovascular Disease: A Short Review. Arch Neurol. 1962;6(2):87–95. doi:10.1001/archneur.1962.00450200001001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: